Paediatric drug development : an opportunity for academia to close the gap

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Possible effects of repeated exposure to ibuprofen and acetaminophen on the intestinal immune response in young infants.

  2016cited by this paper
• Effects of Food and Pharmaceutical Formulation on Desmopressin Pharmacokinetics in Children

  2016cited by this paper
• Bioequivalence in adults does not mean bioequivalence in children

  2016cited by this paper
• Enhanced Paediatric Pharmacovigilance at the European Medicines Agency: A Novel Query Applied to Adverse Drug Reaction Reports

  2016cited by this paper
• The Potential Use of Piglets as Human Pediatric Surrogate for Preclinical Pharmacokinetic and Pharmacodynamic Drug Testing.

  2016cited by this paper
• Neonates and medicines: a roadmap to further improve neonatal pharmaceutical care

  2016cited by this paper
• Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates

  2016cited by this paper
• Therapeutic efficacy and safety of ACE inhibitors in the hypertensive paediatric population: a review

  2016cited by this paper
• Towards a better managed off-label use of drugs

  2015cited by this paper
• Drug disposition in obesity: toward evidence-based dosing.

  2015cited by this paper
• Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children

  2015cited by this paper
• Augmented Renal Clearance Implies a Need for Increased Amoxicillin-Clavulanic Acid Dosing in Critically Ill Children

  2015cited by this paper
• Pediatric Drug Safety Signal Detection: A New Drug–Event Reference Set for Performance Testing of Data-Mining Methods and Systems

  2015cited by this paper
• More is needed by all for transparency in clinical research.

  2015cited by this paper
• An update of juvenile animal studies in the European Union: What do the numbers say?

  2015cited by this paper
• Drug Dosing and Pharmacokinetics in Children With Obesity: A Systematic Review.

  2015cited by this paper
• Oral Presentation

  2015cited by this paper
• Angiotensin converting enzyme inhibitors in pediatrics : state of the art

  2015cited by this paper
• Neonatal medicines research: challenges and opportunities

  2015cited by this paper
• Clinical trials in children.

  2015cited by this paper
• An aid to drug dosing safety in obese children: development of a new nomogram and comparison with existing methods for estimation of ideal body weight and lean body mass

  2015cited by this paper
• A substitution error leading to central anticholinergic syndrome

  2015cited by this paper
• Hypertension in Young People: Epidemiology, Diagnostic Assessment and Therapeutic Approach

  2015influential reference
• Hypertension Prevalence, Cardiac Complications, and Antihypertensive Medication Use in Children.

  2015influential reference
• Neonatal drug therapy: The first frontier of therapeutics for children

  2015cited by this paper
• Pharmacokinetics, Pharmacodynamics, and Safety of Lisinopril in Pediatric Kidney Transplant Patients: Implications for Starting Dose Selection

  2015cited by this paper
• Challenging factors for enuresis treatment: Psychological problems and non-adherence.

  2015cited by this paper
• A prospective study of frequency and characteristics of cough during ACE inhibitor treatment

  2015cited by this paper
• Ethics of Drug Studies in the Newborn

  2015cited by this paper
• Physiologically Based Pharmacokinetic Predictions of Tramadol Exposure Throughout Pediatric Life: an Analysis of the Different Clearance Contributors with Emphasis on CYP2D6 Maturation

  2015cited by this paper
• Practical pharmacokinetics: what do you really need to know?

  2014cited by this paper
• Adult bioequivalence studies insufficient for paediatric use: the case of desmopressin

  2014cited by this paper
• Angiotensin-Converting Enzyme Inhibitor Nephrotoxicity in Neonates with Cardiac Disease

  2014cited by this paper
• European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.

  2014cited by this paper
• Update: Ambulatory Blood Pressure Monitoring in Children and Adolescents A Scientific Statement From the American Heart Association

  2014cited by this paper
• The pediatric studies initiative: after 15 years have we reached the limits of the law?

  2014cited by this paper
• Antihistamine use in children

  2014cited by this paper
• Prospective validation of neonatal vancomycin dosing regimens is urgently needed

  2014cited by this paper
• Safety Profile of Desmopressin Tablet for Enuresis in a Prospective Study

  2014cited by this paper
• Impact of Pediatric Exclusivity on Drug Labeling and Demonstrations of Efficacy

  2014cited by this paper
• Population pharmacokinetic modelling of total and unbound cefazolin plasma concentrations as a guide for dosing in preterm and term neonates.

  2014cited by this paper
• Pharmacological interventions for hypertension in children.

  2014influential reference
• Paediatric clinical pharmacology in the UK

  2014cited by this paper
• Newborns, one of the last therapeutic orphans to be adopted.

  2014cited by this paper
• The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses

  2014cited by this paper
• Neonatal Clinical Pharmacology

  2014cited by this paper
• A retrospective description of anesthetic medication dosing in overweight and obese children

  2014cited by this paper
• European Pediatricians’ Approach to Children With GER Symptoms: Survey of the Implementation of 2009 NASPGHAN-ESPGHAN Guidelines

  2014cited by this paper
• Who are the PDCO?

  2014cited by this paper
• Fetal renin-angiotensin-system blockade syndrome: renal lesions

  2014cited by this paper
• Pharmacokinetics of desmopressin administered as tablet and oral lyophilisate formulation in children with monosymptomatic nocturnal enuresis

  2014cited by this paper
• Pediatric clinical pharmacology: an introduction to a series of educational papers

  2013cited by this paper
• Is there a gender difference in antidiuretic response to desmopressin in children

  2013cited by this paper
• An overview of the pediatric medications for the symptomatic treatment of allergic rhinitis, cough, and cold.

  2013cited by this paper
• Educational Paper: Formulation-related issues in pediatric clinical pharmacology

  2013cited by this paper
• Reflection: medicines for children—science alone is not enough

  2013cited by this paper
• Ethical aspects of clinical research with minors

  2013cited by this paper
• Challenges Evaluating the Safety of Pediatric Therapeutic Agents in Clinical Trials and Post‐Marketing Surveillance

  2013cited by this paper
• The Consent and Assent Process in Pediatric Clinical Trials

  2013cited by this paper
• Ambulatory Blood Pressure Monitoring in Children and Adolescents: Coming of Age?

  2013cited by this paper
• Need for change in implementation of paediatric regulation.

  2013cited by this paper
• In Vitro Cytochrome P450 Activity Decreases in Children with High Pediatric End-Stage Liver Disease Scores

  2013cited by this paper
• Pediatric Clinical Pharmacology in Regulatory and Drug Development Sciences: Lessons Learned and the Path Forward

  2013cited by this paper
• Desmopressin melt improves response and compliance compared with tablet in treatment of primary monosymptomatic nocturnal enuresis

  2013cited by this paper
• Preclinical Safety Assessment: Introduction and Overview

  2013cited by this paper
• Weight depending dosing of desmopressin (dDAVP) in nocturnal enuresis.

  2013cited by this paper
• Association between prescribing hypnotics for parents and children in Norway

  2013cited by this paper
• Cognitive Development Considerations for Long‐term Safety Exposures in Children

  2013cited by this paper
• Educational Paper: Aspects of clinical pharmacology in children—pharmacovigilance and safety

  2013cited by this paper
• Children with cancer: driving the global agenda.

  2013cited by this paper
• History of Children and the Development of Regulations at the FDA

  2013cited by this paper
• Pediatric information in drug product labeling.

  2012cited by this paper
• Sodium Intake and Blood Pressure Among US Children and Adolescents

  2012cited by this paper
• Antihypertensive Drug Use By Children: Are the Drugs Labeled and Indicated?

  2012cited by this paper
• First evidence for weight dependent dosing of desmopressin

  2012cited by this paper
• Medicines for pediatric oncology: can we overcome the failure to deliver?

  2012cited by this paper
• Neonatal and Pediatric Pharmacology: Therapeutic Principles in Practice

  2012cited by this paper
• Introduction to drug pharmacokinetics in the critically ill patient.

  2012cited by this paper
• Cefazolin plasma protein binding and its covariates in neonates

  2012cited by this paper
• Over-prescription of acid-suppressing medications in infants: how it came about, why it's wrong, and what to do about it.

  2012cited by this paper
• Preparation of medicines for children - a hierarchy of classification.

  2012cited by this paper
• Highlights for the Management of a Child with Hypertension

  2012cited by this paper
• Physiologically Based Pharmacokinetic (PBPK) Modeling in Children

  2012cited by this paper
• Evolution of antireflux medication prescriptions in Belgium over the last decade

  2012cited by this paper
• Population survival from childhood cancer in Britain during 1978-2005 by eras of entry to clinical trials.

  2012cited by this paper
• Adverse drug reaction-related admissions in paediatrics, a prospective single-centre study

  2012cited by this paper
• Reference blood pressure values in childhood: an issue to be solved.

  2012cited by this paper
• Pediatric cardiovascular safety: challenges in drug and device development and clinical application.

  2012cited by this paper
• Development of hypertension in adolescents with pre-hypertension.

  2012cited by this paper
• Therapeutic Options for the Treatment of Hypertension in Children and Adolescents

  2012cited by this paper
• Proton Pump Inhibitor Use in Infants: FDA Reviewer Experience

  2012cited by this paper
• The Innovative Medicines Initiative: A European Response to the Innovation Challenge

  2012cited by this paper
• Ethical considerations in conducting pediatric research.

  2011cited by this paper
• A European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA)

  2011cited by this paper
• Reflections on the Innovative Medicines Initiative

  2011cited by this paper
• Pharmacokinetic characteristics of desmopressin oral lyophilisate (MELT) and tablet formulation in children

  2011cited by this paper
• The status of paediatric medicines initiatives around the world—what has happened and what has not?

  2011cited by this paper
• The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials

  2011cited by this paper
• Sample collection, biobanking, and analysis.

  2011cited by this paper
• Role of modeling and simulation in pediatric investigation plans

  2011cited by this paper

• No citing papers are available for this paper.